By Heather Landi
Congress is launching an investigation into concierge healthcare provider One Medical following allegations that the company has been administering COVID-19 vaccinations to ineligible patients.
read more
By Conor Hale
After one year and hundreds of individual diagnostic authorizations for COVID-19, the FDA is now greenlighting more tests that can be performed or started at home, and on a much broader scale.
read more
By Nick Paul Taylor
Novavax is targeting a second-quarter FDA filing for emergency use of its COVID-19 vaccine. The goal suggests the U.S. could join the U.K. on the list of countries to authorize the vaccine in the first half of the year.
read more
By Kevin Dunleavy,Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale
The EU is showing cracks as some supply-starved countries are going outside the bloc to secure COVID-19 vaccines. Johnson & Johnson has teamed with Merck & Co. in a "wartime" alliance to supply vaccines. The FDA has endorsed at-home COVID-19 testing kits from Quidel and Eurofins. Promising results emerge for Cerecor's antibody med.
read more
By Heather Landi
Major healthcare groups are calling for the industry to redouble efforts to collect and report race and ethnicity data when administering COVID-19 vaccinations.
read more
By Paige Minemyer
Blue Cross and Blue Shield of North Carolina saw $200 million in claims related to COVID-19 last year, the insurer said during a briefing Tuesday.
read more
By Ben Adams
Cerecor, which has a market cap of less than $400 million and some small, low-key raises and pacts over the years, saw its shares bounce around 15% premarket this morning on new phase 2 data for its experimental COVID-19 drug.
read more
